The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases

References

• Di Carlo M, Giacomazza D, Picone P, et al. Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases? Free Radic Res 2012;46(11):1327-38
   PubMed Web of Science ®Google Scholar
• Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000;29(3-4):222-30
   PubMed Web of Science ®Google Scholar
• Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006;125(7):1241-52
   PubMed Web of Science ®Google Scholar
• Hildenbeutel M, Habib SJ, Herrmann JM, Rapaport D. New insights into the mechanism of precursor protein insertion into the mitochondrial membranes. Int Rev Cell Mol Biol 2008;268:147-90
   PubMed Web of Science ®Google Scholar
• Chandel NS. Mitochondria as signaling organelles. BMC Biol 2014;12:34
   PubMed Web of Science ®Google Scholar
• Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab 2012;26(6):711-23
   PubMed Web of Science ®Google Scholar
• Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol 2000;529(Pt 1):57-68
   PubMed Web of Science ®Google Scholar
• Luzikov VN. Principles of control over formation of structures responsible for respiratory functions of mitochondria. Biochemistry (Mosc) 2009;74(13):1443-56
   Google Scholar
• Lodish H, Berk A, Zipursky SL, et al. Section 16.1 Oxidation of Glucose and Fatty Acids to CO2. In: Molecular Cell Biology. New York: W.H. Freeman; 2000
   Google Scholar
• Ricquier D, Bouillaud F. Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J Physiol 2000;529(Pt 1):3-10
   PubMed Web of Science ®Google Scholar
• Goetz ME, Luch A. Reactive species: a cell damaging rout assisting to chemical carcinogens. Cancer Lett 2008;266(1):73-83
   PubMed Web of Science ®Google Scholar
• Richter C, Kass GE. Oxidative stress in mitochondria: its relationship to cellular Ca2+ homeostasis, cell death, proliferation, and differentiation. Chem Biol Interact 1991;77(1):1-23
   Google Scholar
• Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160(1):1-40
   PubMed Web of Science ®Google Scholar
• Alfadda AA, Sallam RM. Reactive oxygen species in health and disease. J Biomed Biotechnol 2012; 936486
   Google Scholar
• Gonzalez-Lima F, Barksdale BR, Rojas JC. Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem Pharmacol 2014;88(4):584-93
   PubMed Web of Science ®Google Scholar
• Streck EL, Goncalves CL, Furlanetto CB, et al. Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders. Rev Bras Psiquiatr 2014;36(2):156-67
   PubMed Web of Science ®Google Scholar
• Wong-Riley MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989;12(3):94-101
   PubMed Web of Science ®Google Scholar
• Dato S, Crocco P, D’Aquila P, et al. Exploring the role of genetic variability and lifestyle in oxidative stress response for healthy aging and longevity. Int J Mol Sci 2013;14(8):16443-72
   Google Scholar
• Dai DF, Chiao YA, Marcinek DJ, et al. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan 2014;3:6
   PubMedGoogle Scholar
• Chen H, Chan DC. Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases. Hum Mol Genet 2009;18(R2):R169-76
   PubMed Web of Science ®Google Scholar
• Chang DT, Reynolds IJ. Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture. Neuroscience 2006;141(2):727-36
   Google Scholar
• Sharma J, Johnston MV, Hossain MA. Sex differences in mitochondrial biogenesis determine neuronal death and survival in response to oxygen glucose deprivation and reoxygenation. BMC Neurosci 2014;15:9
   Google Scholar
• McInnes J. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration. Transl Neurodegener 2013;2(1):12
   Google Scholar
• Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008;88(2):611-38
   PubMed Web of Science ®Google Scholar
• Gleyzer N, Vercauteren K, Scarpulla RC. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol 2005;25(4):1354-66
   PubMed Web of Science ®Google Scholar
• Santos RX, Correia SC, Wang X, et al. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer’s disease. J Alzheimers Dis 2010;20(Suppl 2):S401-12
   PubMed Web of Science ®Google Scholar
• Su B, Wang X, Zheng L, et al. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 2010;1802(1):135-42
   PubMed Web of Science ®Google Scholar
• Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999;341(Pt 2):233-49
   PubMed Web of Science ®Google Scholar
• Gottlieb RA, Carreira RS. Autophagy in health and disease. 5. Mitophagy as a way of life. Am J Physiol Cell Physiol 2010;299(2):C203-10
   Google Scholar
• Kanki T, Wang K, Cao Y, et al. Atg32 is a mitochondrial protein that confers selectivity during mitophagy. Dev Cell 2009;17(1):98-109
   PubMed Web of Science ®Google Scholar
• Velarde MC. Mitochondrial and sex steroid hormone crosstalk during aging. Longev Healthspan 2014;3(1):2
   PubMedGoogle Scholar
• Sohal RS, Allen RG. Oxidative stress as a causal factor in differentiation and aging: a unifying hypothesis. Exp Gerontol 1990;25(6):499-522
   Google Scholar
• Herrero-Mendez A, Almeida A, Fernandez E, et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 2009;11(6):747-52
   PubMed Web of Science ®Google Scholar
• Ross JM, Stewart JB, Hagstrom E, et al. Germline mitochondrial DNA mutations aggravate ageing and can impair brain development. Nature 2013;501(7467):412-15
   Google Scholar
• Podlesniy P, Figueiro-Silva J, Llado A, et al. Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol 2013;74(5):655-68
   PubMed Web of Science ®Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med 2010;362(4):329-44
   PubMed Web of Science ®Google Scholar
• Forstl H, Kurz A. Clinical features of Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci 1999;249(6):288-90
   PubMed Web of Science ®Google Scholar
• Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011;1(1):a006189
   PubMed Web of Science ®Google Scholar
• Gregory GC, Macdonald V, Schofield PR, et al. Differences in regional brain atrophy in genetic forms of Alzheimer’s disease. Neurobiol Aging 2006;27(3):387-93
   Google Scholar
• Braak H, Braak E, Yilmazer D, et al. Pattern of brain destruction in Parkinson’s and Alzheimer’s diseases. J Neural Transm 1996;103(4):455-90
   Google Scholar
• Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med 2012;2(5):a006148
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Burns JM, Khan SM. The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 2014;1842(8):1219-31
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Khan SM. A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease. Med Hypotheses 2004;63(1):8-20
   PubMed Web of Science ®Google Scholar
• Resende R, Moreira PI, Proenca T, et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008;44(12):2051-7
   PubMed Web of Science ®Google Scholar
• Manczak M, Anekonda TS, Henson E, et al. Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006;15(9):1437-49
   PubMed Web of Science ®Google Scholar
• Takuma K, Yao J, Huang J, et al. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 2005;19(6):597-8
   PubMed Web of Science ®Google Scholar
• Caspersen C, Wang N, Yao J, et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease. FASEB J 2005;19(14):2040-1
   PubMedGoogle Scholar
• Hirai K, Aliev G, Nunomura A, et al. Mitochondrial abnormalities in Alzheimer’s disease. J Neurosci 2001;21(9):3017-23
   PubMed Web of Science ®Google Scholar
• Nunomura A, Hofer T, Moreira PI, et al.A oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol 2009;118(1):151-66
   PubMed Web of Science ®Google Scholar
• Mohsenzadegan M, Mirshafiey A. The immunopathogenic role of reactive oxygen species in Alzheimer disease. Iran J Allergy Asthma Immunol 2012;11(3):203-16
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhong C. Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 2013;108:21-43
   PubMed Web of Science ®Google Scholar
• Mastrogiacoma F, Lindsay JG, Bettendorff L, et al. Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer’s disease. Ann Neurol 1996;39(5):592-8
   Google Scholar
• Sorbi S, Bird ED, Blass JP. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 1983;13(1):72-8
   Google Scholar
• Correia SC, Santos RX, Santos MS, et al. Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer’s disease. Curr Alzheimer Res 2013;10(4):406-19
   PubMed Web of Science ®Google Scholar
• Lustbader JW, Cirilli M, Lin C, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer’s disease. Science 2004;304(5669):448-52
   PubMed Web of Science ®Google Scholar
• Hansson Petersen CA, Alikhani N, Behbahani H, et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 2008;105(35):13145-50
   PubMed Web of Science ®Google Scholar
• Du H, Guo L, Fang F, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nat Med 2008;14(10):1097-105
   PubMed Web of Science ®Google Scholar
• Wang X, Su B, Perry G, et al. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Free Radic Biol Med 2007;43(12):1569-73
   Google Scholar
• Atamna H. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer’s disease. J Alzheimers Dis 2006;10(2-3):255-66
   Google Scholar
• Dell’agnello C, Leo S, Agostino A, et al. Increased longevity and refractoriness to Ca(2+)-dependent neurodegeneration in Surf1 knockout mice. Hum Mol Genet 2007;16(4):431-44
   Google Scholar
• Moreira PI, Santos MS, Moreno A, et al. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 2002;69(2):257-67
   Google Scholar
• Moreira PI, Santos MS, Moreno A, Oliveira C. Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep 2001;21(6):789-800
   Google Scholar
• Carvalho C, Machado N, Mota P, et al. Type 2 diabetic and Alzheimer’s disease mice present similar behavioral, cognitive and vascular anomalies. J Alzheimer Dis 2013;35:3
   Google Scholar
• Carvalho C, Cardoso S, Correia SC, et al. Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochondrial abnormalities. Diabetes 2012;61(5):1234-42
   PubMed Web of Science ®Google Scholar
• Crouch PJ, Blake R, Duce JA, et al. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci 2005;25(3):672-9
   Google Scholar
• Feldhaus P, Fraga DB, Ghedim FV, et al. Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease. Metab Brain Dis 2011;26(3):229-36
   Google Scholar
• Lovell MA, Xie C, Markesbery WR. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer’s disease. Neurology 1998;51(6):1562-6
   PubMed Web of Science ®Google Scholar
• Pocernich CB, La Fontaine M, Butterfield DA. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem Int 2000;36(3):185-91
   PubMed Web of Science ®Google Scholar
• Moreira PI, Harris PL, Zhu X, et al. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis 2007;12(2):195-206
   PubMedGoogle Scholar
• Charan RA, Johnson BN, Zaganelli S, et al. Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin. Cell Death Dis 2014;5:e1313
   Google Scholar
• Choi JW, Song MY, Park KS. Quantitative proteomic analysis reveals mitochondrial protein changes in MPP(+)-induced neuronal cells. Mol Biosyst 2014;10(7):1940-7
   Google Scholar
• Pinto M, Moraes CT. Mitochondrial genome changes and neurodegenerative diseases. Biochim Biophys Acta 2014;1842(8):1198-207
   PubMed Web of Science ®Google Scholar
• Hawkes CH. Parkinson’s disease and aging: same or different process? Mov Disord 2008;23(1):47-53
   Google Scholar
• Cheon SM, Ha MS, Park MJ, Kim JW. Nonmotor symptoms of Parkinson’s disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord 2008;14(4):286-90
   PubMed Web of Science ®Google Scholar
• Braak H, Muller CM, Rub U, et al. Pathology associated with sporadic Parkinson’s disease–where does it end? J Neural Transm Suppl 2006(70):89-97
   Google Scholar
• Mazzetti AP, Fiorile MC, Primavera A, Lo Bello M. Glutathione transferases and neurodegenerative diseases. Neurochem Int 2015;82:10-18
   PubMed Web of Science ®Google Scholar
• Reeve AK, Krishnan KJ, Turnbull DM. Age related mitochondrial degenerative disorders in humans. Biotechnol J 2008;3(6):750-6
   Google Scholar
• Zheng B, Liao Z, Locascio JJ, et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson’s disease. Sci Transl Med 2010;2(52):52ra73
   PubMed Web of Science ®Google Scholar
• Betarbet R, Sherer TB, MacKenzie G, et al. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 2000;3(12):1301-6
   PubMed Web of Science ®Google Scholar
• Schapira AH, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1989;1(8649):1269
   PubMed Web of Science ®Google Scholar
• Parker WDJr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson’s disease. Ann Neurol 1989;26(6):719-23
   PubMed Web of Science ®Google Scholar
• Perrine DM. N-methyl-(R)-salsolinol and Parkinson’s disease. Lancet 1998;351(9118):1818
   Google Scholar
• Fornai F, Schluter OM, Lenzi P, et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 2005;102(9):3413-18
   PubMed Web of Science ®Google Scholar
• Schapira AH. Mitochondrial dysfunction in Parkinson’s disease. Cell Death Differ 2007;14(7):1261-6
   PubMed Web of Science ®Google Scholar
• Hauser DN, Hastings TG. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease and monogenic parkinsonism. Neurobiol Dis 2013;51:35-42
   PubMed Web of Science ®Google Scholar
• Soong NW, Hinton DR, Cortopassi G, Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 1992;2(4):318-23
   Google Scholar
• Autere J, Moilanen JS, Finnila S, et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia. Hum Genet 2004;115(1):29-35
   Google Scholar
• Smigrodzki R, Parks J, Parker WD. High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging. Neurobiol Aging 2004;25(10):1273-81
   Google Scholar
• Davidzon G, Greene P, Mancuso M, et al. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 2006;59(5):859-62
   Google Scholar
• Hudson G, Schaefer AM, Taylor RW, et al. Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. Arch Neurol 2007;64(4):553-7
   Google Scholar
• Luoma PT, Eerola J, Ahola S, et al. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology 2007;69(11):1152-9
   PubMed Web of Science ®Google Scholar
• Arduino DM, Esteves AR, Cortes L, et al. Mitochondrial metabolism in Parkinson’s disease impairs quality control autophagy by hampering microtubule-dependent traffic. Hum Mol Genet 2012;21(21):4680-702
   Google Scholar
• Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008;4(11):600-9
   PubMedGoogle Scholar
• Navarro A, Boveris A. Brain mitochondrial dysfunction and oxidative damage in Parkinson’s disease. J Bioenerg Biomembr 2009;41(6):517-21
   Google Scholar
• Keeney PM, Xie J, Capaldi RA, Bennett JPJr. Parkinson’s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 2006;26(19):5256-64
   PubMed Web of Science ®Google Scholar
• Sumathipala DS, Jayasekara RW, Dissanayake VH. Clinical and genetic features of Huntington disease in Sri Lanka. BMC Neurol 2013;13:191
   Google Scholar
• Khatri N, Man HY. Synaptic activity and bioenergy homeostasis: implications in brain trauma and neurodegenerative diseases. Front Neurol 2013;4:199
   PubMed Web of Science ®Google Scholar
• Costa V, Scorrano L. Shaping the role of mitochondria in the pathogenesis of Huntington’s disease. EMBO J 2012;31(8):1853-64
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443(7113):787-95
   PubMed Web of Science ®Google Scholar
• Zheng Z, Diamond MI. Huntington disease and the huntingtin protein. Prog Mol Biol Transl Sci 2012;107:189-214
   PubMed Web of Science ®Google Scholar
• Itoh K, Nakamura K, Iijima M, Sesaki H. Mitochondrial dynamics in neurodegeneration. Trends Cell Biol 2013;23(2):64-71
   PubMed Web of Science ®Google Scholar
• Cepeda-Prado E, Popp S, Khan U, et al. R6/2 Huntington’s disease mice develop early and progressive abnormal brain metabolism and seizures. J Neurosci 2012;32(19):6456-67
   Google Scholar
• Bossy-Wetzel E, Petrilli A, Knott AB. Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 2008;31(12):609-16
   Google Scholar
• Massieu L, Del Rio P, Montiel T. Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Neuroscience 2001;106(4):669-77
   Google Scholar
• Greene JG, Greenamyre JT. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J Neurochem 1995;64(1):430-6
   Google Scholar
• Benchoua A, Trioulier Y, Zala D, et al. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 2006;17(4):1652-63
   PubMed Web of Science ®Google Scholar
• Reddy PH, Mao P, Manczak M. Mitochondrial structural and functional dynamics in Huntington’s disease. Brain Res Rev 2009;61(1):33-48
   PubMedGoogle Scholar
• Damiano M, Diguet E, Malgorn C, et al. A role of mitochondrial complex II defects in genetic models of Huntington’s disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet 2013;22(19):3869-82
   PubMed Web of Science ®Google Scholar
• Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 2014
   Google Scholar
• Siddiqui A, Rivera-Sanchez S, Castro Mdel R, et al. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington’s disease. Free Radic Biol Med 2012;53(7):1478-88
   PubMed Web of Science ®Google Scholar
• Ribeiro M, Rosenstock TR, Cunha-Oliveira T, et al. Glutathione redox cycle dysregulation in Huntington’s disease knock-in striatal cells. Free Radic Biol Med 2012;53(10):1857-67
   Google Scholar
• Mason RP, Casu M, Butler N, et al. Glutathione peroxidase activity is neuroprotective in models of Huntington’s disease. Nat Genet 2013;45(10):1249-54
   Google Scholar
• Cagalinec M, Safiulina D, Liiv M, et al. Principles of the mitochondrial fusion and fission cycle in neurons. J Cell Sci 2013;126(Pt 10):2187-97
   PubMed Web of Science ®Google Scholar
• Corrado M, Scorrano L, Campello S. Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases. Int J Cell Biol 2012;2012:729290
   PubMedGoogle Scholar
• Wang X, Su B, Lee HG, et al. Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J Neurosci 2009;29(28):9090-103
   PubMed Web of Science ®Google Scholar
• Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer’s disease: implications for neuronal damage. Hum Mol Genet 2011;20(13):2495-509
   PubMed Web of Science ®Google Scholar
• Wang S, Song J, Tan M, et al. Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer’s disease. Eur J Neurol 2012;19(7):1015-22
   Google Scholar
• Cho DH, Nakamura T, Fang J, et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009;324(5923):102-5
   PubMed Web of Science ®Google Scholar
• Wang X, Su B, Fujioka H, Zhu X. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer’s disease patients. Am J Pathol 2008;173(2):470-82
   PubMed Web of Science ®Google Scholar
• Wang X, Su B, Siedlak SL, et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008;105(49):19318-23
   PubMed Web of Science ®Google Scholar
• Manczak M, Reddy PH. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer’s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 2012;21(11):2538-47
   PubMed Web of Science ®Google Scholar
• Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 2006;103(8):2653-8
   PubMed Web of Science ®Google Scholar
• Zhu X, Perry G, Smith MA, Wang X. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis 2013;33(Suppl 1):S253-62
   Google Scholar
• Wang X, Wang W, Li L, et al. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta 2014;1842(8):1240-7
   PubMed Web of Science ®Google Scholar
• Chen H, Vermulst M, Wang YE, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010;141(2):280-9
   PubMed Web of Science ®Google Scholar
• Hroudova J, Singh N, Fisar Z. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer’s disease. Biomed Res Int 2014;2014:175062
   PubMed Web of Science ®Google Scholar
• Poole AC, Thomas RE, Andrews LA, et al. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 2008;105(5):1638-43
   PubMed Web of Science ®Google Scholar
• Yang Y, Ouyang Y, Yang L, et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA 2008;105(19):7070-5
   PubMed Web of Science ®Google Scholar
• Dagda RK, Cherra SJ3rd, Kulich SM, et al. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 2009;284(20):13843-55
   PubMed Web of Science ®Google Scholar
• Lutz AK, Exner N, Fett ME, et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 2009;284(34):22938-51
   PubMed Web of Science ®Google Scholar
• Exner N, Treske B, Paquet D, et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 2007;27(45):12413-18
   Google Scholar
• Wang X, Yan MH, Fujioka H, et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet 2012;21(9):1931-44
   PubMed Web of Science ®Google Scholar
• Kamp F, Exner N, Lutz AK, et al. Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 2010;29(20):3571-89
   PubMed Web of Science ®Google Scholar
• Sheng ZH, Cai Q. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 2012;13(2):77-93
   PubMed Web of Science ®Google Scholar
• Yang F, Jiang Q, Zhao J, et al. Parkin stabilizes microtubules through strong binding mediated by three independent domains. J Biol Chem 2005;280(17):17154-62
   Google Scholar
• Gillardon F. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability–a point of convergence in parkinsonian neurodegeneration? J Neurochem 2009;110(5):1514-22
   Google Scholar
• Liot G, Bossy B, Lubitz S, et al. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 2009;16(6):899-909
   PubMed Web of Science ®Google Scholar
• Costa V, Giacomello M, Hudec R, et al. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington’s disease to apoptotic stimuli. EMBO Mol Med 2010;2(12):490-503
   PubMed Web of Science ®Google Scholar
• Chang CR, Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann N Y Acad Sci 2010;1201:34-9
   PubMed Web of Science ®Google Scholar
• Moreira PI, Siedlak SL, Wang X, et al. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 2007;66(6):525-32
   PubMed Web of Science ®Google Scholar
• Lauri A, Pompilio G, Capogrossi MC. The mitochondrial genome in aging and senescence. Ageing Res Rev 2014;18C:1-15
   Web of Science ®Google Scholar
• Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 2007;462(2):245-53
   PubMed Web of Science ®Google Scholar
• Nemes Z, Devreese B, Steinert PM, et al. Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer’s neurofibrillary tangles. FASEB J 2004;18(10):1135-7
   PubMedGoogle Scholar
• Ye X, Sun X, Starovoytov V, Cai Q. Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer’s disease patient brains. Hum Mol Genet 2015;24(10):2938-51
   PubMed Web of Science ®Google Scholar
• Corsetti V, Florenzano F, Atlante A, et al. NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer’s disease. Hum Mol Genet 2015;24(11):3058-81
   PubMed Web of Science ®Google Scholar
• Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008;183(5):795-803
   PubMed Web of Science ®Google Scholar
• Narendra DP, Jin SM, Tanaka A, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. Plos Biol 2010;8(1):e1000298
   PubMed Web of Science ®Google Scholar
• Mijaljica D, Prescott M, Klionsky DJ, Devenish RJ. Autophagy and vacuole homeostasis: a case for self-degradation? Autophagy 2007;3(5):417-21
   PubMed Web of Science ®Google Scholar
• Vives-Bauza C, Zhou C, Huang Y, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 2010;107(1):378-83
   PubMed Web of Science ®Google Scholar
• Matsuda N, Sato S, Shiba K, et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 2010;189(2):211-21
   PubMed Web of Science ®Google Scholar
• Hampe C, Ardila-Osorio H, Fournier M, et al. Biochemical analysis of Parkinson’s disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum Mol Genet 2006;15(13):2059-75
   Google Scholar
• Banerjee R, Beal MF, Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci 2010;33(12):541-9
   PubMed Web of Science ®Google Scholar
• Barsoum MJ, Yuan H, Gerencser AA, et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 2006;25(16):3900-11
   PubMed Web of Science ®Google Scholar
• Martinez-Vicente M, Talloczy Z, Wong E, et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington’s disease. Nat Neurosci 2010;13(5):567-76
   PubMed Web of Science ®Google Scholar
• Cherra SJ3rd, Chu CT. Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol 2008;3(3):309-23
   PubMedGoogle Scholar
• Pedros I, Petrov D, Allgaier M, et al. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer’s disease. Biochim Biophys Acta 2014;1842(9):1556-66
   Google Scholar
• Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008;9(7):505-18
   PubMed Web of Science ®Google Scholar
• Sheng B, Wang X, Su B, et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease. J Neurochem 2012;120(3):419-29
   PubMed Web of Science ®Google Scholar
• Qin W, Haroutunian V, Katsel P, et al. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 2009;66(3):352-61
   PubMedGoogle Scholar
• Swerdlow RH. beta-Apptists and Tauists, it is time for a sermon from the book of biogenesis. J Neurochem 2012;120(3):347-9
   Google Scholar
• Silva DF, Selfridge JE, Lu J, et al. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum Mol Genet 2013;22(19):3931-46
   PubMed Web of Science ®Google Scholar
• Manczak M, Jung Y, Park BS, et al. Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem 2005;92(3):494-504
   PubMed Web of Science ®Google Scholar
• Liang WS, Reiman EM, Valla J, et al. Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 2008;105(11):4441-6
   Google Scholar
• de la Monte SM, Luong T, Neely TR, et al. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer’s disease. Lab Invest 2000;80(8):1323-35
   PubMedGoogle Scholar
• Chandrasekaran K, Giordano T, Brady DR, et al. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res Mol Brain Res 1994;24(1-4):336-40
   Google Scholar
• Shaerzadeh F, Motamedi F, Khodagholi F. Inhibition of akt phosphorylation diminishes mitochondrial biogenesis regulators, tricarboxylic acid cycle activity and exacerbates recognition memory deficit in rat model of Alzheimer’s disease. Cell Mol Neurobiol 2014;34(8):1223-33
   PubMed Web of Science ®Google Scholar
• Zhang W, Gu GJ, Shen X, et al. Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer’s disease-like pathology. Neurobiol Aging 2015;36(3):1282-92
   PubMed Web of Science ®Google Scholar
• Dumont M, Stack C, Elipenahli C, et al. PGC-1alpha overexpression exacerbates beta-amyloid and tau deposition in a transgenic mouse model of Alzheimer’s disease. FASEB J 2014;28(4):1745-55
   PubMed Web of Science ®Google Scholar
• St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006;127(2):397-408
   PubMed Web of Science ®Google Scholar
• Ciron C, Zheng L, Bobela W, et al. PGC-1alpha activity in nigral dopamine neurons determines vulnerability to alpha-synuclein. Acta Neuropathol Commun 2015;3(1):16
   Google Scholar
• Thomas RR, Keeney PM, Bennett JP. Impaired complex-I mitochondrial biogenesis in Parkinson disease frontal cortex. J Parkinsons Dis 2012;2(1):67-76
   PubMedGoogle Scholar
• Weydt P, Pineda VV, Torrence AE, et al. Thermoregulatory and metabolic defects in Huntington’s disease transgenic mice implicate PGC-1alpha in Huntington’s disease neurodegeneration. Cell Metab 2006;4(5):349-62
   PubMed Web of Science ®Google Scholar
• Weydt P, Soyal SM, Gellera C, et al. The gene coding for PGC-1alpha modifies age at onset in Huntington’s Disease. Mol Neurodegener 2009;4:3
   PubMed Web of Science ®Google Scholar
• Cui L, Jeong H, Borovecki F, et al. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006;127(1):59-69
   PubMed Web of Science ®Google Scholar
• Johri A, Calingasan NY, Hennessey TM, et al. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington’s disease. Hum Mol Genet 2012;21(5):1124-37
   Google Scholar
• Lin J, Wu PH, Tarr PT, et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004;119(1):121-35
   PubMed Web of Science ®Google Scholar
• Dumont M, Stack C, Elipenahli C, et al. Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice. Hum Mol Genet 2012;21(23):5091-105
   Google Scholar
• Iyer S, Thomas RR, Portell FR, et al. Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression. Mitochondrion 2009;9(3):196-203
   PubMed Web of Science ®Google Scholar
• Shokolenko IN, Alexeyev MF, LeDoux SP, Wilson GL. The approaches for manipulating mitochondrial proteome. Environ Mol Mutagen 2010;51(5):451-61
   Google Scholar
• Keeney PM, Quigley CK, Dunham LD, et al. Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson’s disease cell model. Hum Gene Ther 2009;20(8):897-907
   Google Scholar
• Correia S, Carvalho C, Santos MS, et al. Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Med Chem 2008;4(4):358-64
   Google Scholar
• Sun AY, Wang Q, Simonyi A, Sun GY. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 2010;41(2-3):375-83
   PubMed Web of Science ®Google Scholar
• Leick L, Fentz J, Bienso RS, et al. PGC-1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2010;299(3):E456-65
   PubMed Web of Science ®Google Scholar
• Campello S, Lacalle RA, Bettella M, et al. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J Exp Med 2006;203(13):2879-86
   Google Scholar
• Li Z, Okamoto K, Hayashi Y, Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004;119(6):873-87
   PubMed Web of Science ®Google Scholar
• Macaskill AF, Rinholm JE, Twelvetrees AE, et al. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009;61(4):541-55
   PubMed Web of Science ®Google Scholar
• MacAskill AF, Kittler JT. Control of mitochondrial transport and localization in neurons. Trends Cell Biol 2010;20(2):102-12
   PubMedGoogle Scholar
• Stokin GB, Goldstein LS. Axonal transport and Alzheimer’s disease. Annu Rev Biochem 2006;75:607-27
   PubMed Web of Science ®Google Scholar
• Wang X, Su B, Zheng L, et al. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J Neurochem 2009;109(Suppl 1):153-9
   PubMed Web of Science ®Google Scholar
• Rui Y, Tiwari P, Xie Z, Zheng JQ. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 2006;26(41):10480-7
   PubMed Web of Science ®Google Scholar
• Guo L, Du H, Yan S, et al. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer’s neurons. Plos One 2013;8(1):e54914
   PubMed Web of Science ®Google Scholar
• Calkins MJ, Manczak M, Mao P, et al. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer’s disease. Hum Mol Genet 2011;20(23):4515-29
   PubMed Web of Science ®Google Scholar
• Trushina E, Nemutlu E, Zhang S, et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer’s disease. Plos One 2012;7(2):e32737
   PubMed Web of Science ®Google Scholar
• Wang X, Winter D, Ashrafi G, et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011;147(4):893-906
   PubMed Web of Science ®Google Scholar
• Scarffe LA, Stevens DA, Dawson VL, Dawson TM. Parkin and PINK1: much more than mitophagy. Trends Neurosci 2014;37(6):315-24
   PubMed Web of Science ®Google Scholar
• Liu G, Zhang C, Yin J, et al. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett 2009;454(3):187-92
   PubMed Web of Science ®Google Scholar
• Weihofen A, Thomas KJ, Ostaszewski BL, et al. Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 2009;48(9):2045-52
   PubMed Web of Science ®Google Scholar
• Orr AL, Li S, Wang CE, et al. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 2008;28(11):2783-92
   PubMed Web of Science ®Google Scholar
• Trushina E, Dyer RB, Badger JD2nd, et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 2004;24(18):8195-209
   PubMed Web of Science ®Google Scholar
• Chang DT, Rintoul GL, Pandipati S, Reynolds IJ. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 2006;22(2):388-400
   Google Scholar
• Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007;404(1):1-13
   PubMed Web of Science ®Google Scholar
• Dali-Youcef N, Lagouge M, Froelich S, et al. Sirtuins: the ’magnificent seven’, function, metabolism and longevity. Ann Med 2007;39(5):335-45
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Guarente L. Sirtuins at a glance. J Cell Sci 2011;124(Pt 6):833-8
   PubMed Web of Science ®Google Scholar
• Pellegrini L, Pucci B, Villanova L, et al. SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ 2012;19(11):1815-25
   Google Scholar
• Kong X, Wang R, Xue Y, et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. Plos One 2010;5(7):e11707
   PubMed Web of Science ®Google Scholar
• Shih J, Donmez G. Mitochondrial sirtuins as therapeutic targets for age-related disorders. Genes Cancer 2013;4(3-4):91-6
   PubMedGoogle Scholar
• Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 2010;35(12):669-75
   PubMed Web of Science ®Google Scholar
• Lombard DB, Alt FW, Cheng HL, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 2007;27(24):8807-14
   PubMed Web of Science ®Google Scholar
• Ahn BH, Kim HS, Song S, et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA 2008;105(38):14447-52
   PubMed Web of Science ®Google Scholar
• Hirschey MD, Shimazu T, Goetzman E, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010;464(7285):121-5
   PubMed Web of Science ®Google Scholar
• Shimazu T, Hirschey MD, Hua L, et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 2010;12(6):654-61
   PubMed Web of Science ®Google Scholar
• Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005;280(14):13560-7
   PubMed Web of Science ®Google Scholar
• Someya S, Yu W, Hallows WC, et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010;143(5):802-12
   PubMed Web of Science ®Google Scholar
• Donmez G. The neurobiology of sirtuins and their role in neurodegeneration. Trends Pharmacol Sci 2012;33(9):494-501
   PubMed Web of Science ®Google Scholar
• Kim SH, Lu HF, Alano CC. Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture. Plos One 2011;6(3):e14731
   Google Scholar
• Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000;289(5487):2126-8
   PubMed Web of Science ®Google Scholar
• Weir HJ, Murray TK, Kehoe PG, et al.CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer’s disease. Plos One 2012;7(11):e48225
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Gupta M, Kim G, et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009;119(9):2758-71
   PubMed Web of Science ®Google Scholar
• Song W, Song Y, Kincaid B, et al. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1alpha. Neurobiol Dis 2013;51:72-81
   PubMed Web of Science ®Google Scholar
• Fu J, Jin J, Cichewicz RH, et al. trans-(-)-epsilon-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease. J Biol Chem 2012;287(29):24460-72
   PubMed Web of Science ®Google Scholar
• Han P, Tang Z, Yin J, et al. Pituitary adenylate cyclase-activating polypeptide protects against beta-amyloid toxicity. Neurobiol Aging 2014;35(9):2064-71
   Google Scholar
• Liu L, Peritore C, Ginsberg J, et al. SIRT3 attenuates MPTP-induced nigrostriatal degeneration via enhancing mitochondrial antioxidant capacity. Neurochem Res 2015;40(3):600-8
   Google Scholar
• Kurochkin IV, Goto S. Alzheimer’s beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 1994;345(1):33-7
   Google Scholar
• Du J, Zhou Y, Su X, et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011;334(6057):806-9
   PubMed Web of Science ®Google Scholar
• Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275(5303):1129-32
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127(6):1109-22
   PubMed Web of Science ®Google Scholar
• Ou X, Lee MR, Huang X, et al. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 2014;32(5):1183-94
   PubMed Web of Science ®Google Scholar
• Outeiro TF, Marques O, Kazantsev A. Therapeutic role of sirtuins in neurodegenerative disease. Biochim Biophys Acta 2008;1782(6):363-9
   PubMed Web of Science ®Google Scholar
• Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004;305(5686):1010-13
   PubMed Web of Science ®Google Scholar
• Green KN, Steffan JS, Martinez-Coria H, et al. Nicotinamide restores cognition in Alzheimer’s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 2008;28(45):11500-10
   PubMed Web of Science ®Google Scholar
• Langley B, Gensert JM, Beal MF, Ratan RR. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord 2005;4(1):41-50
   Google Scholar
• Kim D, Nguyen MD, Dobbin MM, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J 2007;26(13):3169-79
   PubMed Web of Science ®Google Scholar
• Qin W, Yang T, Ho L, et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 2006;281(31):21745-54
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 2005;280(48):40364-74
   PubMed Web of Science ®Google Scholar
• Li H, Rajendran GK, Liu N, et al. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. Breast Cancer Res 2007;9(1):R1
   Google Scholar
• Marwarha G, Raza S, Meiers C, Ghribi O. Leptin attenuates BACE1 expression and amyloid-beta genesis via the activation of SIRT1 signaling pathway. Biochim Biophys Acta 2014;1842(9):1587-95
   Google Scholar
• Donmez G, Arun A, Chung CY, et al.1 protects against alpha-synuclein aggregation by activating molecular chaperones. J Neurosci 2012;32(1):124-32
   PubMed Web of Science ®Google Scholar
• Kakefuda K, Fujita Y, Oyagi A, et al. Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Biochem Biophys Res Commun 2009;387(4):784-8
   Google Scholar
• Parker JA, Arango M, Abderrahmane S, et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005;37(4):349-50
   PubMed Web of Science ®Google Scholar
• Ho DJ, Calingasan NY, Wille E, et al. Resveratrol protects against peripheral deficits in a mouse model of Huntington’s disease. Exp Neurol 2010;225(1):74-84
   PubMed Web of Science ®Google Scholar
• Sano M, Fukuda K. Activation of mitochondrial biogenesis by hormesis. Circ Res 2008;103(11):1191-3
   Google Scholar
• Ristow M, Schmeisser S. Extending life span by increasing oxidative stress. Free Radic Biol Med 2011;51(2):327-36
   PubMed Web of Science ®Google Scholar
• Schwartz DR, Sack MN. Targeting the mitochondria to augment myocardial protection. Curr Opin Pharmacol 2008;8(2):160-5
   Google Scholar
• Kirkland JL. Perspectives on cellular senescence and short term dietary restriction in adults. Aging (Albany NY) 2010;2(12):894-6
   Google Scholar
• Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp Gerontol 2010;45(6):410-18
   PubMed Web of Science ®Google Scholar
• Calabrese V, Cornelius C, Dinkova-Kostova AT, et al. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal 2010;13(11):1763-811
   PubMed Web of Science ®Google Scholar
• Cornelius C, Perrotta R, Graziano A, et al. Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: Mitochondria as a "chi". Immun Ageing 2013;10(1):15
   Google Scholar
• Cornelius C, Trovato Salinaro A, Scuto M, et al. Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: role of vitagenes. Immun Ageing 2013;10(1):41
   Google Scholar
• Lima DC, Cossa AC, Perosa SR, et al. Neuroglobin is up-regulated in the cerebellum of pups exposed to maternal epileptic seizures. Int J Dev Neurosci 2011;29(8):891-7
   Google Scholar
• Yu Z, Liu N, Liu J, et al. Neuroglobin, a Novel Target for Endogenous Neuroprotection against Stroke and Neurodegenerative Disorders. Int J Mol Sci 2012;13(6):6995-7014
   PubMed Web of Science ®Google Scholar
• Bonilla-Ramirez L, Jimenez-Del-Rio M, Velez-Pardo C. Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile parkinsonism. Gene 2013;512(2):355-63
   Google Scholar
• Jones RG, Plas DR, Kubek S, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005;18(3):283-93
   PubMed Web of Science ®Google Scholar
• Vingtdeux V, Giliberto L, Zhao H, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 2010;285(12):9100-13
   PubMed Web of Science ®Google Scholar
• Puigserver P, Wu Z, Park CW, et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998;92(6):829-39
   PubMed Web of Science ®Google Scholar
• Brown GC. Nitric oxide and mitochondria. Front Biosci 2007;12:1024-33
   PubMed Web of Science ®Google Scholar
• Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 200o;310(5746):314-17
   Google Scholar